Home › Mieloma multiplo › New York › Greenburgh
Studi clinici su Mieloma multiplo a Greenburgh, NY
13 studi su Mieloma multiplo cercano partecipanti presso sedi a Greenburgh e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
In reclutamentoFase 2
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · a 9 mi di distanza
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
In reclutamentoFase 3
- MSK Bergen, Montvale · a 9 mi di distanza
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
In reclutamentoFase 2
- Phelps Hospital, Sleepy Hollow · a 4 mi di distanza
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
In reclutamentoFase 2
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · a 9 mi di distanza
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
In reclutamentoFase 3
- MSK Bergen, Montvale · a 9 mi di distanza
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
In reclutamentoFase 1
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · a 9 mi di distanza
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
In reclutamentoStudio osservazionale
- Memorial Sloan Kettering Bergen (Consent Only), Montvale · a 9 mi di distanza
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
In reclutamentoFase 1/2
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · a 9 mi di distanza
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
In reclutamentoFase 2
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · a 9 mi di distanza
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
In reclutamentoFase 2
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · a 9 mi di distanza
A Dietary Study for People With Multiple Myeloma
In reclutamento
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · a 9 mi di distanza
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
In reclutamentoFase 2
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · a 9 mi di distanza
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
In reclutamento
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · a 9 mi di distanza
Studi su Mieloma multiplo in altre città
- New York City, NY60 studi
- Boston, MA42 studi
- Atlanta, GA41 studi
- Houston, TX38 studi
- Durham, NC37 studi
- Nashville, TN32 studi
- Denver, CO27 studi
- Rochester, MN24 studi
- St. Louis, MO24 studi
- Columbus, OH24 studi
- Baldwin Park, CA23 studi
- Chicago, IL22 studi
Altri studi a Greenburgh
- Cancro al seno42 studi
- Cancro del polmone non a piccole cellule28 studi
- Leucemia mieloide acuta18 studi
- Cancro alla prostata17 studi
- Cancro (tutti i tipi)17 studi
- Cancro ai polmoni17 studi
- Cancro colorettale11 studi
- Cancro metastatico11 studi
- Cancro dell'endometrio11 studi
- Cancro della vescica10 studi
- Carcinoma a cellule squamose della testa e del collo9 studi
- Linfoma9 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.